Enterostatin
肠抑素
Report date: 2024/11/29 15:12:21
NME
Base Information
Drug NameEnterostatin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstra
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksWikipedia